Catch the latest updates to the MHRA transition period guidances

The Medicines and Healthcare products Regulatory Agency (MHRA) has published further guidance and updates in relation to supplying medicines and medical devices after the end of the transition period.

The updated guidance on medical devices includes new information surrounding Northern Ireland (NI).

The following guidances on medicines have also been updated:

In a letter to the industry, the MHRA has also provided guidance on post-transition conversion of Community Marketing Authorisations to Great Britain Marketing Authorisations.

Additionally, the Department of Health and Social Care (DHSC) has published updated guidance on the reporting requirements for medicines shortages and discontinuations. Click here to view this guidance.

Further guidance and updates from the MHRA is planned over the coming weeks.